MULTI SCIENCES
Human CEACAM6/CD66c ELISA Kit Distributor
Human CEACAM6/CD66c ELISA Kit Distributor
SKU:EK1224
Product Details
Brand | MultiSciences |
---|---|
CatNum | 70-EK1224 |
Product Name | Human CEACAM6/CD66c ELISA Kit |
Customs Name | Human CEACAM6/CD66c ELISA Kit |
Application | ELISA |
Reactivity | Human |
Assay Type | Sandwich ELISA |
Suitable Sample Type | serum, plasma, cell culture supernates |
Format | 96-well strip plate |
Storage | 4℃ (unopened) standard stored at -20℃, others stored at 4℃ (opened) |
Shipping Condition | 4℃ |
Sample Volume | 100 μl (prediluted) |
Sensitivity | 1.41 pg/ml |
Standard Curve Range | 15.63 - 1000 pg/ml |
Spike Recovery Range | 90 % - 119 % |
Mean Spike Recovery | 1.09 |
CV of Intra plate | 4.2 % - 4.8 % |
CV of Inter plate | 3.9 % - 4.9 % |
Components | 96-well polystyrene microplate coated with a monoclonal antibody against CEACAM6 Human CEACAM6 Standard, lyophilized CEACAM6 Detect Antibody Standard Diluent Streptavidin-HRP Assay Buffer (10×) Substrate (TMB) Stop Solution Washing Buffer (20×) Plate Covers |
Describtion | This assay employs the quantitative sandwich enzyme immunoassay technique for the quantitative detection of human CEACAM6. The Human CEACAM6/CD66c ELISA is for research use only. Not for diagnostic or therapeutic procedures. Carcinoembryonic antigen-related cell adhesion molecule 6 (CEACAM6), also known as CD66c, is one of seven human CEACAM family members. It's a glycosylphosphatidylinositol-linked immunoglobulin superfamily member that is overexpressed in a variety of human cancers, including colon, breast and lung and is associated with tumourigenesis, tumour cell adhesion, invasion and metastasis. CEACAM6 is expressed by granulocytes and their progenitors. It is also expressed by epithelia of various organs and is upregulated in pancreatic and colon adenocarcinomas, as well as hyperplastic polyps. Resistance to adhesion-related apoptosis in tumor cells is conferred in the condition of CEACAM6 overexpression. Overexpression of CEACAM6 promotes migration and invasion of oestrogen-deprived breast cancer cells and suggest that this protein could be an important biomarker of metastasis. |
